Paper · 686171
Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.
DeLean A and 2 others. Am J Physiol, 1978. Cited by 3,519 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Papers, record 686171. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/686171
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Computers | Major topic |
| Dose-Response Relationship, Drug | Major topic |
| Dose-Response Relationship, Immunologic | Major topic |
| Binding, Competitive | |
| Biological Assay | |
| Nucleic Acid Hybridization | |
| Radioimmunoassay | |
| Statistics as Topic |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 16,091,391 | Estimation of dose-response curves and identification of peaks in hormone pulsations: classic marriages of statistics to science. | https://conductscience.org/library/papers/16091391 |
Source PubMed
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by620
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,519 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,924,182 | Elucidation of Selective Apoptosis of Breast Cancer Cells Induced by Panax ginseng-Derived Exosomes via Regulation of Bax/Bcl-2 Ratio and AMPK-α Signaling. | Int J Breast Cancer | 2026 | https://conductscience.org/library/papers/42924182 | PubMed |
| 42,872,010 | A Human Glucoregulatory Model for the Rational Design and Evaluation of Diabetes Therapeutics. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42872010 | PubMed |
| 42,181,044 | Days to re-entrainment following the spring and autumn changes in local clock time: Beyond simple heuristics. | Front Photon | 2024 | https://conductscience.org/library/papers/42181044 | PubMed |
| 41,626,434 | Consequences of mRNA Secondary Structure on Stability against both Hydrolysis and Aggregation: The Role of Electrostatic, π-π Stacking, and Thermal Effects. | ACS Omega | 2026 | https://conductscience.org/library/papers/41626434 | PubMed |
| 41,530,473 | Best practices in the application of parallelism for biomarker assay validation. | AAPS J | 2026 | https://conductscience.org/library/papers/41530473 | PubMed |
| 41,413,110 | Liposomal co-delivery of β-carotene and doxorubicin for enhanced colorectal-cancer therapy. | Sci Rep | 2025 | https://conductscience.org/library/papers/41413110 | PubMed |
| 41,261,367 | Usability of Amorphous Manganese Oxide for Assessing the Proteoglycan Content in Articular Cartilage. | Magn Reson Chem | 2026 | https://conductscience.org/library/papers/41261367 | PubMed |
| 41,170,426 | RPA-assisted CRISPR-Cas12a-enabled point-of-care diagnostic platform for chili leaf curl virus with fluorescent and colorimetric readouts. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41170426 | PubMed |
| 40,775,424 | PEGylated liposomal metformin overcomes pharmacokinetic barriers to trigger potent mitochondrial disruption and cell cycle arrest in hepatocellular carcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/40775424 | PubMed |
| 40,448,296 | Assessments of CYP-Inhibition-Based Drug-Drug Interactions Between Tofacitinib and Lipid-Lowering Agents in Rats Both In Vitro and In Vivo. | Pharmacol Res Perspect | 2025 | https://conductscience.org/library/papers/40448296 | PubMed |
1 to 10 of 620
See all 620 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/686171
GET https://conductscience.org/api/papers/v1/686171/cited_by?page=2